Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $3,020 | 2 | 51.0% |
| Food and Beverage | $1,646 | 72 | 27.8% |
| Travel and Lodging | $1,259 | 6 | 21.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $4,417 | 9 | $0 (2023) |
| Grifols USA, LLC | $189.31 | 9 | $0 (2024) |
| Insmed, Inc. | $174.37 | 9 | $0 (2024) |
| GENZYME CORPORATION | $151.20 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $114.91 | 6 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $96.72 | 4 | $0 (2024) |
| United Therapeutics Corporation | $86.13 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $65.82 | 4 | $0 (2024) |
| Mylan Specialty L.P. | $56.08 | 3 | $0 (2024) |
| Genentech USA, Inc. | $54.27 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $571.86 | 28 | Grifols USA, LLC ($87.76) |
| 2023 | $5,050 | 42 | Intuitive Surgical, Inc. ($4,417) |
| 2022 | $303.87 | 10 | GENZYME CORPORATION ($125.00) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $38.71 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Pulmonology | ||||||
| 09/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 08/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Pulmonology | ||||||
| 08/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.63 | General |
| Category: HFCWO | ||||||
| 08/13/2024 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 07/31/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 07/11/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $31.04 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Baxter Healthcare | Hillrom - Monarch Airway Clearance System (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Airway Clearance Device | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2024 | Siemens Medical Solutions USA, Inc. | Cios Spin (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: AT - Mobile interventional x-ray/angiography fluoroscopy | ||||||
| 04/18/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Medical Device | ||||||
| 04/17/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Respiratory | ||||||
| 04/11/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Pulmonology | ||||||
| 04/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Pulmonology | ||||||
| 03/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Immunology | ||||||
| 02/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Inflammation | ||||||
| 02/15/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,363 | 1,891 | $421,636 | $159,251 |
| 2022 | 8 | 246 | 391 | $101,488 | $38,860 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 171 | 402 | $169,242 | $65,053 | 38.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 192 | 372 | $74,250 | $33,230 | 44.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 133 | 197 | $26,989 | $11,645 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 132 | $32,076 | $11,511 | 35.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 76 | 78 | $29,562 | $10,178 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 65 | 65 | $20,670 | $7,350 | 35.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $6,890 | $3,653 | 53.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $8,806 | $3,171 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 45 | $7,740 | $2,795 | 36.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 50 | 52 | $15,132 | $2,365 | 15.6% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 22 | 26 | $6,360 | $1,862 | 29.3% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 18 | 18 | $5,742 | $1,613 | 28.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 120 | 121 | $2,904 | $1,074 | 37.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 15 | 15 | $2,775 | $951.15 | 34.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 117 | 118 | $2,124 | $772.59 | 36.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 90 | 91 | $2,275 | $696.14 | 30.6% |
| 76604 | Ultrasound scan of chest | Facility | 2023 | 25 | 27 | $1,701 | $549.50 | 32.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $728.00 | $371.80 | 51.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 43 | 43 | $860.00 | $257.46 | 29.9% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 14 | 14 | $490.00 | $150.50 | 30.7% |
| 31623 | Exam of lung airways using an endoscope | Facility | 2023 | 15 | 15 | $4,320 | $1.20 | 0.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 58 | 112 | $47,152 | $18,230 | 38.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 72 | 141 | $19,317 | $7,529 | 39.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 57 | $11,343 | $4,374 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $6,042 | $2,365 | 39.1% |
About Dr. Dafang Chen, MD
Dr. Dafang Chen, MD is a Pulmonary Disease healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2016. The National Provider Identifier (NPI) number assigned to this provider is 1710341433.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dafang Chen, MD has received a total of $5,925 in payments from pharmaceutical and medical device companies, with $571.86 received in 2024. These payments were reported across 80 transactions from 26 companies. The most common payment nature is "Education" ($3,020).
As a Medicare-enrolled provider, Chen has provided services to 1,609 Medicare beneficiaries, totaling 2,282 services with total Medicare billing of $198,111. Data is available for 2 years (2022–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Louisville, KY
- Active Since 04/08/2016
- Last Updated 08/19/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1710341433
Products in Payments
- ION (Device) $3,000
- Da Vinci Surgical System (Device) $1,417
- Prolastin-C Liquid (Biological) $189.31
- Arikayce (Drug) $174.37
- ARALAST (Biological) $99.49
- TYVASO (Drug) $86.13
- OPSUMIT (Drug) $76.93
- DUPIXENT (Biological) $67.53
- TRELEGY ELLIPTA (Drug) $65.82
- Xolair (Biological) $54.27
- CHARTIS CATHETER (Device) $46.53
- TEZSPIRE (Biological) $45.10
- OFEV (Drug) $41.85
- ZERBAXA (Drug) $37.45
- ALIYA SYSTEM (Device) $36.43
- Kcentra (Biological) $34.53
- YUPELRI (Drug) $28.69
- Yupelri (Drug) $27.39
- Cresemba (Drug) $22.31
- UPTRAVI (Drug) $19.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Louisville
Dr. John Mcconnell, M.d, M.D
Pulmonary Disease — Payments: $1.0M
Harold Haller, Md, MD
Pulmonary Disease — Payments: $397,803
Kenneth Anderson, Md, MD
Pulmonary Disease — Payments: $16,989
Dr. Edwin Carmouche, Md, MD
Pulmonary Disease — Payments: $15,169
Dr. Zaka Khan, Md, MD
Pulmonary Disease — Payments: $15,042
Dr. Allan Ramirez, M.d, M.D
Pulmonary Disease — Payments: $12,934